CardioFocus(R) Announces FDA Approval Of The Next-Generation HeartLight(R) Excalibur Balloon(TM) Designed For The Treatment Of Paroxysmal Atrial Fibrillation

MARLBOROUGH, Mass., May 7, 2018 -- (Healthcare Sales & Marketing Network) -- CardioFocus, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the HeartLight Excalibur Balloon, a next-generation technology designe... Devices, Cardiology, FDA CardioFocus, HeartLight Excalibur, atrial fibrillation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news